(SOLB) Solvay - Ratings and Ratios
Exchange: BR • Country: Belgium • Currency: EUR • Type: Common Stock • ISIN: BE0003470755
SOLB EPS (Earnings per Share)
SOLB Revenue
SOLB: Sodium Carbonate, Sodium Bicarbonate, Hydrogen Peroxide, Precipitated Silica, Fluorine Formulations
Solvay SA is a global chemical company that produces a wide range of essential chemicals, including sodium carbonate, sodium bicarbonate, hydrogen peroxide, precipitated silica, solvents, and polyamide chain products. These chemicals are used in various industries such as construction, automotive, electronics, and consumer goods. The companys products are used in the production of glass, detergents, food, and pharmaceuticals, as well as in the manufacturing of lithium-ion batteries for electric vehicles.
With a history dating back to 1863, Solvay SA has established itself as a leader in the chemical industry, with a diverse portfolio of products and a global presence. The companys commitment to innovation and sustainability has enabled it to stay ahead of the curve, with a focus on developing chemicals that are used in emerging technologies such as renewable energy and electric vehicles.
From a technical analysis perspective, Solvay SAs stock price has been trending around its 20-day and 50-day simple moving averages (SMA20 and SMA50), indicating a stable short-term outlook. However, the stock is still below its 200-day SMA, suggesting a potential long-term downtrend. The Average True Range (ATR) is relatively low, indicating low volatility. Given the current price of 29.76 EUR, a potential trading range could be between 28.86 EUR (29.76 - 0.90 ATR) and 30.66 EUR (29.76 + 0.90 ATR).
Fundamentally, Solvay SAs market capitalization stands at 3035.75M EUR, with a price-to-earnings (P/E) ratio of 15.52 and a forward P/E ratio of 7.36, indicating a relatively undervalued stock. The companys return on equity (RoE) is 14.81%, suggesting a decent level of profitability. Using the available fundamental data, we can forecast that Solvay SAs earnings per share (EPS) will increase by around 10-15% in the next year, driven by growing demand for its chemicals in emerging technologies. This could lead to a potential price target of around 33-35 EUR, representing a 10-15% upside from current levels.
Combining both technical and fundamental analysis, we can conclude that Solvay SA is a stable company with a strong track record of innovation and a diverse portfolio of products. While the stock price may be subject to some short-term volatility, the companys fundamental strengths and growth prospects make it an attractive investment opportunity in the chemicals sector. A potential trading strategy could involve buying the stock on dips towards 28.86 EUR, with a target price of 33-35 EUR.
Additional Sources for SOLB Stock
SOLB Stock Overview
Market Cap in USD | 3,610m |
Sector | Basic Materials |
Industry | Chemicals |
GiC Sub-Industry | Diversified Chemicals |
IPO / Inception |
SOLB Stock Ratings
Growth Rating | 71.4 |
Fundamental | 1.83 |
Dividend Rating | 47.0 |
Rel. Strength | -3.21 |
Analysts | - |
Fair Price Momentum | 35.72 EUR |
Fair Price DCF | 58.73 EUR |
SOLB Dividends
Dividend Yield 12m | 8.31% |
Yield on Cost 5y | 37.67% |
Annual Growth 5y | -8.31% |
Payout Consistency | 93.8% |
Payout Ratio | 61.7% |
SOLB Growth Ratios
Growth Correlation 3m | -35.7% |
Growth Correlation 12m | -13.2% |
Growth Correlation 5y | 96.1% |
CAGR 5y | 34.00% |
CAGR/Max DD 5y | 1.32 |
Sharpe Ratio 12m | 0.41 |
Alpha | -16.54 |
Beta | 0.354 |
Volatility | 35.21% |
Current Volume | 211k |
Average Volume 20d | 213.4k |
As of June 26, 2025, the stock is trading at EUR 28.74 with a total of 210,965 shares traded.
Over the past week, the price has changed by -0.76%, over one month by -2.97%, over three months by -12.35% and over the past year by -3.34%.
Neither. Based on ValueRay´s Fundamental Analyses, Solvay is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 1.83 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of SOLB is around 35.72 EUR . This means that SOLB is currently undervalued and has a potential upside of +24.29% (Margin of Safety).
Solvay has no consensus analysts rating.
According to our own proprietary Forecast Model, SOLB Solvay will be worth about 38.6 in June 2026. The stock is currently trading at 28.74. This means that the stock has a potential upside of +34.24%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 32 | 11.2% |
Analysts Target Price | - | - |
ValueRay Target Price | 38.6 | 34.2% |